Literature DB >> 22357889

Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications.

Hebert Alberto Vargas1, Oguz Akin, Tobias Franiel, Debra A Goldman, Kazuma Udo, Karim A Touijer, Victor E Reuter, Hedvig Hricak.   

Abstract

PURPOSE: To describe the anatomic features of the central zone of the prostate on T2-weighted and diffusion-weighted (DW) magnetic resonance (MR) images and evaluate the diagnostic performance of MR imaging in detection of central zone involvement by prostate cancer.
MATERIALS AND METHODS: The institutional review board waived informed consent and approved this retrospective, HIPAA-compliant study of 211 patients who underwent T2-weighted and DW MR imaging of the prostate before radical prostatectomy. Whole-mount step-section pathologic findings were the reference standard. Two radiologists independently recorded the visibility, MR signal intensity, size, and symmetry of the central zone and scored the likelihood of central zone involvement by cancer on T2-weighted MR images and on T2-weighted MR images plus apparent diffusion coefficient (ADC) maps generated from the DW MR images. Descriptive summary statistics were calculated for central zone imaging features. Sensitivity, specificity, and area under the curve were used to evaluate reader performance in detecting central zone involvement.
RESULTS: For readers 1 and 2, the central zone was visible, at least partially, in 177 (84%) and 170 (81%) of 211 patients, respectively. The most common imaging appearance of the central zone was symmetric, homogeneous low signal intensity. Cancers involving the central zone had higher prostate-specific antigen values, Gleason scores, and rates of extracapsular extension and seminal vesicle invasion compared with cancers not involving the central zone (P < .05). Area under the curve, sensitivity, and specificity in detecting central zone involvement were 0.70, 0.30, and 0.96 for reader 1 and 0.65, 0.35, and 0.93 for reader 2, and these values did not differ significantly between T2-weighted imaging and T2-weighted imaging plus ADC maps.
CONCLUSION: The central zone was visualized in most patients. Cancers involving the central zone were associated with more aggressive disease than those without central zone involvement. © RSNA, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 22357889      PMCID: PMC3285222          DOI: 10.1148/radiol.11110663

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  25 in total

1.  Central zone histology of the prostate: a mimicker of high-grade prostatic intraepithelial neoplasia.

Authors:  Monica Srodon; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

2.  MR depiction of zonal anatomy of the prostate at 1.5 T.

Authors:  F G Sommer; J E McNeal; C L Carrol
Journal:  J Comput Assist Tomogr       Date:  1986 Nov-Dec       Impact factor: 1.826

3.  Regional morphology and pathology of the prostate.

Authors:  J E McNeal
Journal:  Am J Clin Pathol       Date:  1968-03       Impact factor: 2.493

4.  Comparison of peripheral zone and central gland volume in patients undergoing intensity-modulated radiotherapy.

Authors:  Christian M Zechmann; Tobias Simpfendörfer; Frederik L Giesel; Patrik Zamecnik; Christian Thieke; Thomas Hielscher; Hans-Peter Meinzer; Stefan Delorme
Journal:  J Comput Assist Tomogr       Date:  2010 Sep-Oct       Impact factor: 1.826

5.  An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.

Authors:  M Noguchi; T A Stamey; J E Neal; C E Yemoto
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

6.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.

Authors:  Aytekin Oto; Arda Kayhan; Yulei Jiang; Maria Tretiakova; Cheng Yang; Tatjana Antic; Farid Dahi; Arieh L Shalhav; Gregory Karczmar; Walter M Stadler
Journal:  Radiology       Date:  2010-09-15       Impact factor: 11.105

7.  Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?

Authors:  Jin Iwazawa; Takashi Mitani; Seitaro Sassa; Shoichi Ohue
Journal:  Diagn Interv Radiol       Date:  2010-09-22       Impact factor: 2.630

8.  The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.

Authors:  Charles M Quick; Neriman Gokden; Ankur R Sangoi; James D Brooks; Jesse K McKenney
Journal:  Hum Pathol       Date:  2010-04-22       Impact factor: 3.466

9.  MR imaging of the prostate gland: normal anatomy.

Authors:  H Hricak; G C Dooms; J E McNeal; A S Mark; M Marotti; A Avallone; M Pelzer; E C Proctor; E A Tanagho
Journal:  AJR Am J Roentgenol       Date:  1987-01       Impact factor: 3.959

10.  Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread.

Authors:  J E McNeal; E A Redwine; F S Freiha; T A Stamey
Journal:  Am J Surg Pathol       Date:  1988-12       Impact factor: 6.394

View more
  19 in total

1.  Diagnosis of typical and atypical transition zone prostate cancer and its mimics at multiparametric prostate MRI.

Authors:  Jinxing Yu; Ann S Fulcher; Sarah G Winks; Mary A Turner; Ryan D Clayton; Michael Brooks; Sean Li
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

2.  The central zone has increased 68Ga-PSMA-11 uptake: "Mickey Mouse ears" can be hot on 68Ga-PSMA-11 PET.

Authors:  Daniele A Pizzuto; Julian Müller; Urs Mühlematter; Niels J Rupp; Antonia Töpfer; Ashkan Mortezavi; Hannes Nagel; Benedikt Kranzbühler; Daniel Eberli; Irene A Burger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

3.  Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.

Authors:  Dmitry Volkin; Baris Turkbey; Anthony N Hoang; Soroush Rais-Bahrami; Nitin Yerram; Annerleim Walton-Diaz; Jeffrey W Nix; Bradford J Wood; Peter L Choyke; Peter A Pinto
Journal:  BJU Int       Date:  2014-10-18       Impact factor: 5.588

4.  Apical periurethral transition zone lesions: MRI and histology findings.

Authors:  Sena Tuncer; Sherif Mehralivand; Stephanie A Harmon; Thomas Sanford; G Thomas Brown; Lindsay S Rowe; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Abdom Radiol (NY)       Date:  2020-10

5.  Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.

Authors:  Rajan T Gupta; Christopher R Kauffman; Kirema Garcia-Reyes; Mark L Palmeri; John F Madden; Thomas J Polascik; Andrew B Rosenkrantz
Journal:  AJR Am J Roentgenol       Date:  2015-08       Impact factor: 3.959

6.  Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Authors:  Anwar R Padhani; Jeffrey Weinreb; Andrew B Rosenkrantz; Geert Villeirs; Baris Turkbey; Jelle Barentsz
Journal:  Eur Urol       Date:  2018-06-13       Impact factor: 20.096

7.  Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.

Authors:  Katsuhiro Ito; Akihiro Furuta; Akira Kido; Yuki Teramoto; Shusuke Akamatsu; Naoki Terada; Toshinari Yamasaki; Takahiro Inoue; Osamu Ogawa; Takashi Kobayashi
Journal:  Int J Clin Oncol       Date:  2019-12-02       Impact factor: 3.402

Review 8.  Functional and molecular imaging of localized and recurrent prostate cancer.

Authors:  Kinzya Grant; Maria L Lindenberg; Haytham Shebel; Yuxi Pang; Harsh K Agarwal; Marcelino Bernardo; Karen A Kurdziel; Baris Turkbey; Peter L Choyke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-07       Impact factor: 9.236

Review 9.  Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.

Authors:  Yu Xuan Kitzing; Adilson Prando; Celi Varol; Gregory S Karczmar; Fiona Maclean; Aytekin Oto
Journal:  Radiographics       Date:  2015-11-20       Impact factor: 5.333

10.  Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes.

Authors:  Arnauld Villers; Philippe Puech; Vincent Flamand; Georges-Pascal Haber; Mihir M Desai; Sebastien Crouzet; Xavier Leroy; Sameer Chopra; Laurent Lemaitre; Adil Ouzzane; Inderbir S Gill
Journal:  Eur Urol       Date:  2016-09-06       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.